A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas
- PMID: 12447857
- DOI: 10.1053/jhep.2002.37261
A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas
Abstract
Primary hepatocellular carcinoma (HCC) is a significant cause of cancer morbidity and mortality on the global scale. Although epidemiologic studies have identified major risk factors for HCC, the sequence of oncogenic events at the molecular level remains poorly understood. While genetic allele loss appears to be a common event, the significance of the loss is not clear. In order to determine whether allele loss appears to be a random event among HCCs or whether patterns of loss cluster in groups of tumors, a phylogenetic approach was used to examine 32 tumors for genome-wide loss of heterozygosity employing 391 markers. Clusters identified by the phylogenetic analysis were then contrasted to compare candidate locus variation among individuals and to determine whether certain clusters exhibited higher loss rates than other clusters. The analysis found that 3 major and 1 minor cluster of loss could be identified and, further, these clusters were distinguished by variable rates of loss (cluster 1, 29%; cluster 2, 21%; cluster 3, 16%). The analyses also indicated that the allele loss rates in HCC were not insignificant and that the patterns of allele loss were complex. In addition, the results indicated that an individual's constitutional genotype at the EPHX1 locus may be a critical factor in determining the path of tumor evolution. In conclusion, it appears that in HCC, allele loss is not random, but clusters into definable groups that are characterized by distinctive rates of loss.
Similar articles
-
Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.Clin Cancer Res. 2006 Sep 1;12(17):5248-52. doi: 10.1158/1078-0432.CCR-06-0558. Clin Cancer Res. 2006. PMID: 16951245
-
Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.Cancer. 2006 Aug 1;107(3):579-90. doi: 10.1002/cncr.22023. Cancer. 2006. PMID: 16795071
-
UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.Am J Gastroenterol. 2005 Aug;100(8):1758-63. doi: 10.1111/j.1572-0241.2005.41857.x. Am J Gastroenterol. 2005. PMID: 16086712
-
[Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].Korean J Hepatol. 2009 Mar;15(1):7-14. doi: 10.3350/kjhep.2009.15.1.7. Korean J Hepatol. 2009. PMID: 19346781 Review. Korean.
-
Molecular mechanisms in hepatocellular carcinoma development.Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):25-37. doi: 10.1016/j.bpg.2004.11.005. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757803 Review.
Cited by
-
The evolution of tumour phylogenetics: principles and practice.Nat Rev Genet. 2017 Apr;18(4):213-229. doi: 10.1038/nrg.2016.170. Epub 2017 Feb 13. Nat Rev Genet. 2017. PMID: 28190876 Free PMC article. Review.
-
Algorithms to model single gene, single chromosome, and whole genome copy number changes jointly in tumor phylogenetics.PLoS Comput Biol. 2014 Jul 31;10(7):e1003740. doi: 10.1371/journal.pcbi.1003740. eCollection 2014 Jul. PLoS Comput Biol. 2014. PMID: 25078894 Free PMC article.
-
Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment.World J Gastroenterol. 2005 Jul 14;11(26):4102-7. doi: 10.3748/wjg.v11.i26.4102. World J Gastroenterol. 2005. PMID: 15996039 Free PMC article.
-
Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.World J Gastroenterol. 2004 Dec 1;10(23):3414-8. doi: 10.3748/wjg.v10.i23.3414. World J Gastroenterol. 2004. PMID: 15526358 Free PMC article.
-
Genomic instability in hepatocellular carcinoma revealed by using the random amplified polymorphic DNA method.J Cancer Res Clin Oncol. 2004 Dec;130(12):757-61. doi: 10.1007/s00432-004-0613-4. Epub 2004 Sep 15. J Cancer Res Clin Oncol. 2004. PMID: 15375656
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous